Theravance Respiratory Company, LLC (Tables)

9 Months Ended

Sep. 30, 2021

Theravance Respiratory Company, LLC

Summary financial information

	Three Months Ended				Nine Months Ended
	September 30,				September 30,
(In thousands)	2021		2020		2021		2020
Royalty revenue and gross profit	$	35,585	$	16,375	$	84,055	$	58,143
Income from continuing operations		35,391		15,768		80,244		56,785
Net income	$	35,539	$	15,768	$	79,655	$	56,822